Making the transition to SMILE has benefited my patients and my practice

Article

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Related Content
Clinical outcomes and patient satisfaction achieved with a corneal approach for managing presbyopia – a case with special significance

Clinical outcomes and patient satisfaction achieved with a corneal approach for managing presbyopia – a case with special significance

Arnaldo Espaillat, MD
August 22nd 2025
Article
Site Logo

Back to the cornea – Treating hyperopic patients with Lenticule Extraction

Prof. Dan Z. Reinstein, MD MA(Cantab) FRCSC FRCOphth DABO FEBO
August 22nd 2025
Article
To Infinity and (PRES)BYOND - The game changer for my practice

To Infinity and (PRES)BYOND - The game changer for my practice

Lourens van Zyl, MBChB, FCOphth, FRANZCO, FRCSI, FEBO, MMed (RefCatSurg), FWCRSVS
August 22nd 2025
Article
Spectacle independence for presbyopic patients: Achieving success and satisfaction with ZEISS PRESBYOND, even in a highly demanding cohort

Spectacle independence for presbyopic patients: Achieving success and satisfaction with ZEISS PRESBYOND, even in a highly demanding cohort

Dan Z Reinstein, MD, MA(Cantab), FWCRS, FRCOphth, FRCSC, DABO, FEBO, PG Dip CRS, Cert LRS
August 22nd 2025
Article
Site Logo

Corneal refractive surgery for presbyopia: why ZEISS PRESBYOND was our preferred solution

Dr. Anke Messerschmidt-Roth
August 22nd 2025
Article
Achieving spectacle independence with PRESBYOND Laser Blended Vision

Achieving spectacle independence with PRESBYOND Laser Blended Vision

Wayne Crewe-Brown, MD
August 22nd 2025
Article
© 2025 MJH Life Sciences

All rights reserved.